Stock Rich List
#527 on the corporate holders of 809 holders

ALS Invest 1 B.V.

10% owner at Amylyx Pharmaceuticals.

$154M
in disclosed stock, −$2.5M (−1.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
527th of 809
Companies held
1
Largest holding
AMLX, 100.0% of total
Latest SEC filing
Jul 6, 2022

What the $154M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Amylyx Pharmaceuticals AMLX
Common Stock
Directly5,895,280$26.20$154M100.0%Form 4, Jul 6, 2022

Share counts are the amounts ALS Invest 1 B.V. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
524Virtu Employee Holdco LLC
Director, Virtu Financial
$156M+$2.7M (+1.74%)
525Slta V (gp), L.l.c.
Director, Dell Technologies
$155M−$317K (−0.20%)
526White Mountains Insurance Group LTD
10% owner, MediaAlpha
$155M−$3.6M (−2.26%)
527ALS Invest 1 B.V.
10% owner, Amylyx Pharmaceuticals
$154M−$2.5M (−1.58%)
528Boxer Capital Management, LLC
Insider, Tango Therapeutics
$154M+$5.6M (+3.75%)
529Yorktown Energy Partners IX, L.P.
10% owner, Riley Exploration Permian
$154M−$637K (−0.41%)
530Third Rock Ventures V, L.P.
Director, Rapport Therapeutics
$154M+$1.2M (+0.81%)

Other Amylyx Pharmaceuticals insiders

All AMLX insiders

Questions

How much stock does ALS Invest 1 B.V. own?

ALS Invest 1 B.V. holds $154,456,336 in listed stock based on SEC filings and current prices, mostly Amylyx Pharmaceuticals (AMLX). That ranks 527th on the Stock Rich List.

Is this ALS Invest 1 B.V.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.